Bradyphrenia
Showing 1 - 25 of 66
Parkinson Disease Trial in Bern, Geneva (Dopaminergic OFF-drug state, Dopaminergic ON-drug state)
Recruiting
- Parkinson Disease
- Dopaminergic OFF-drug state
- Dopaminergic ON-drug state
-
Bern, Switzerland
- +3 more
Jan 11, 2023
Parkinson Disease Trial in Prague, Bern (Dopaminergic OFF drug state, DBS OFF state, Dopaminergic ON drug state)
Recruiting
- Parkinson Disease
- Dopaminergic OFF drug state
- +3 more
-
Prague, Czechia
- +1 more
Feb 28, 2023
Anxiety Trial in Solothurn (200 mcg LSD, 20 mcg LSD, Therapy)
Completed
- Anxiety
- 200 mcg LSD
- +2 more
-
Solothurn, SwitzerlandPrivate Practices of Peter Gasser MD
Feb 16, 2022
Healthy Study Participants, Impaired Hepatic Function Trial in Orlando (Padsevonil)
Terminated
- Healthy Study Participants
- Impaired Hepatic Function
-
Orlando, FloridaUp0056 004
Jul 8, 2021
Multiple Myeloma Trial in Worldwide (Carfilzomib, Dexamethasone)
Completed
- Multiple Myeloma
-
Scottsdale, Arizona
- +139 more
Sep 9, 2022
Diffuse Cutaneous Systemic Sclerosis Trial in United States (JBT-101, Placebo, Part B Open-Label Extension)
Terminated
- Diffuse Cutaneous Systemic Sclerosis
- JBT-101
- +2 more
-
Los Angeles, California
- +8 more
Mar 25, 2021
Huntington's Disease Trial in Worldwide (WVE-120101, Placebo)
Terminated
- Huntington's Disease
- WVE-120101
- Placebo
-
Sidney, New South Wales, Australia
- +20 more
Feb 9, 2022
Parkinson Disease Trial in Madrid (Neuropsychological rehabilitation)
Unknown status
- Parkinson Disease
- Neuropsychological rehabilitation
-
Madrid, SpainHospital Beata María Ana
Apr 5, 2021
Generalized Tonic Clonic Seizures Trial in Worldwide (Pregabalin Dose Level 1, Pregabalin Dose Level 2, Placebo)
Completed
- Generalized Tonic Clonic Seizures
- Pregabalin Dose Level 1
- +2 more
-
Loxahatchee Groves, Florida
- +126 more
Jan 15, 2021
"Retrospective Study to Identify Clinical Factors Related toHigh
Completed
- Carcinoma, Renal Cell
-
Hospitalet de Llobregat, Barcelona, Spain
- +39 more
Feb 15, 2022
Hepatocellular Carcinoma Trial in Worldwide (Tivantinib, Placebo)
Healthy Participants Trial in Leiden (Padsevonil, Placebo (PSL))
Terminated
- Healthy Participants
- Padsevonil
- Placebo (PSL)
-
Leiden, NetherlandsUp0071 001
May 21, 2021
H1N1 Influenza Healthy Volunteers Trial run by the NIAID (CR6261, Placebo)
Completed
- H1N1 Influenza Healthy Volunteers
- CR6261
- Placebo
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Mar 6, 2020
Partial-Onset or Primary Generalized Tonic-Clonic Seizures Trial in Worldwide (Perampanel)
Completed
- Partial-Onset or Primary Generalized Tonic-Clonic Seizures
-
Little Rock, Arkansas
- +91 more
Jan 11, 2022
Healthy Volunteers Trial in Glendale, Salt Lake City (TAK-418, TAK-418 Matching Placebo)
Terminated
- Healthy Volunteers
- TAK-418
- TAK-418 Matching Placebo
-
Glendale, California
- +1 more
Jun 3, 2020
Diabetic Neuropathy, Painful Trial in Worldwide (pregabalin (Lyrica), Placebo)
Completed
- Diabetic Neuropathy, Painful
- pregabalin (Lyrica)
- Placebo
-
Birmingham, Alabama
- +171 more
Jan 15, 2021
Breast Cancer Trial in Worldwide (Palbociclib, Standard Adjuvant Endocrine Therapy)
Active, not recruiting
- Breast Cancer
- Palbociclib
- Standard Adjuvant Endocrine Therapy
-
Mobile, Alabama
- +437 more
Mar 21, 2022
GVHD Trial in Worldwide (Begelomab, Conventional Second-line Treatment)
Terminated
- Graft vs Host Disease
- Begelomab
- Conventional Second-line Treatment
-
Duarte, California
- +26 more
Jan 20, 2020
ALK-positive NSCLC Trial in Worldwide (Ceritinib)
Completed
- ALK-positive Non-small Cell Lung Cancer
-
Los Angeles, California
- +56 more
Apr 8, 2020